Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell Lines

Malgorzata Broncel1, Paul H Huang2

  • 1The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK. malgorzata.broncel@crick.ac.uk.

Insights

Researchers developed a two-stage method to isolate and identify phosphotyrosine peptides, crucial for understanding cancer signaling pathways. This technique helps characterize basal signaling in non-small cell lung cancer (NSCLC) cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein tyrosine kinases regulate critical cell signaling pathways.
  • Dysregulated tyrosine kinase activity is implicated in oncogenesis, particularly in non-small cell lung cancer (NSCLC).
  • Identifying phosphotyrosine (pY)-containing peptides is essential for mapping these signaling networks.

Purpose of the Study:

  • To establish a robust two-stage isolation method for phosphotyrosine peptides.
  • To characterize basal signaling networks in unstimulated NSCLC cell lines.
  • To improve the identification of phosphosites using mass spectrometry.

Main Methods:

  • Utilized a two-stage isolation strategy for phosphotyrosine peptides from cellular lysates.
  • Employed antibody and/or metal affinity-based enrichment techniques.
  • Leveraged mass spectrometry for phosphosite identification.

Main Results:

  • Successfully isolated and identified phosphotyrosine peptides from NSCLC cell lines.
  • Characterized basal signaling networks in unstimulated NSCLC cells.
  • Demonstrated a robust method for phosphoproteomic analysis.

Conclusions:

  • The described two-stage isolation and mass spectrometry-aided identification method is effective for characterizing basal phosphotyrosine signaling.
  • This approach provides valuable insights into the molecular mechanisms of NSCLC.
  • The methodology can be applied to further dissect kinase signaling in cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.5K